Welcome to LookChem.com Sign In|Join Free

CAS

  • or

18672-02-1

Post Buying Request

18672-02-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

18672-02-1 Usage

Description

6-Chloro-2-quinazolinamine, an organic compound with the formula C8H6ClN3, is a member of the quinazoline and derivatives class. It is characterized by a quinazoline moiety that contains two carbon, four nitrogen, and one chlorine atom. This chemical is widely used in chemical research and development, and due to its reactive nature, it can be utilized in producing other complex compounds, particularly in the pharmaceutical industry. However, it must be handled with care due to its potential toxic properties.

Uses

Used in Pharmaceutical Industry:
6-Chloro-2-quinazolinamine is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its reactive nature allows for the creation of complex molecules that can be used in the development of new drugs.
Used in Chemical Research:
6-Chloro-2-quinazolinamine is used as a research compound in the field of organic chemistry. It serves as a starting material for the synthesis of other quinazoline derivatives, which can be further studied for their chemical properties and potential applications.
Used in Drug Development:
6-Chloro-2-quinazolinamine is used as a building block in the development of new drugs, particularly in the pharmaceutical industry. Its ability to form complex compounds makes it a valuable asset in the creation of novel therapeutic agents.
Used in Organic Synthesis:
6-Chloro-2-quinazolinamine is used as a reagent in organic synthesis, allowing for the formation of a wide range of quinazoline-based compounds. These compounds can be further modified and studied for their potential applications in various fields, including medicine and materials science.
Used in Material Science:
6-Chloro-2-quinazolinamine is used as a component in the development of new materials, such as polymers and coatings, that can benefit from the unique properties of quinazoline-based compounds. Its incorporation into these materials can lead to improved performance and functionality.

Check Digit Verification of cas no

The CAS Registry Mumber 18672-02-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,6,7 and 2 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 18672-02:
(7*1)+(6*8)+(5*6)+(4*7)+(3*2)+(2*0)+(1*2)=121
121 % 10 = 1
So 18672-02-1 is a valid CAS Registry Number.

18672-02-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-chloroquinolin-2-amine

1.2 Other means of identification

Product number -
Other names 2-amino-6-chloroquinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:18672-02-1 SDS

18672-02-1Downstream Products

18672-02-1Relevant articles and documents

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 00751; 00752, (2021/01/22)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Page/Page column 207, (2014/09/29)

Compounds of general formula (I) and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Page/Page column 220, (2014/09/29)

Compounds of general formula (I) and compositions comprising compounds of general formula (I) that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 18672-02-1